BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24302565)

  • 1. Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2: Use of potential alternative start sites and implications for predicting variant pathogenicity.
    Parsons MT; Whiley PJ; Beesley J; Drost M; de Wind N; Thompson BA; Marquart L; Hopper JL; Jenkins MA; ; Brown MA; Tucker K; Warwick L; Buchanan DD; Spurdle AB
    Mol Carcinog; 2015 Jul; 54(7):513-22. PubMed ID: 24302565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of proper bioinformatics analysis and clinical interpretation of tumor genomic profiling: a case study of undifferentiated sarcoma and a constitutional pathogenic BRCA2 mutation and an MLH1 variant of uncertain significance.
    Varga E; Chao EC; Yeager ND
    Fam Cancer; 2015 Sep; 14(3):481-5. PubMed ID: 25712765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.
    Pagenstecher C; Wehner M; Friedl W; Rahner N; Aretz S; Friedrichs N; Sengteller M; Henn W; Buettner R; Propping P; Mangold E
    Hum Genet; 2006 Mar; 119(1-2):9-22. PubMed ID: 16341550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient use of a translation start codon in BDNF exon I.
    Koppel I; Tuvikene J; Lekk I; Timmusk T
    J Neurochem; 2015 Sep; 134(6):1015-25. PubMed ID: 25868795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
    Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
    PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.
    Thomassen M; Blanco A; Montagna M; Hansen TV; Pedersen IS; Gutiérrez-Enríquez S; Menéndez M; Fachal L; Santamariña M; Steffensen AY; Jønson L; Agata S; Whiley P; Tognazzo S; Tornero E; Jensen UB; Balmaña J; Kruse TA; Goldgar DE; Lázaro C; Diez O; Spurdle AB; Vega A
    Breast Cancer Res Treat; 2012 Apr; 132(3):1009-23. PubMed ID: 21769658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surviving without BRCA2: MLH1 gets R-looped in to curtail genomic instability.
    Johnson N
    J Clin Invest; 2024 Apr; 134(7):. PubMed ID: 38557488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of the vascular endothelial growth factor internal ribosome entry site (IRES) activity and translation initiation by alternatively spliced coding sequences.
    Bornes S; Boulard M; Hieblot C; Zanibellato C; Iacovoni JS; Prats H; Touriol C
    J Biol Chem; 2004 Apr; 279(18):18717-26. PubMed ID: 14764596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of mismatch repair gene transcripts: issues for interpretation of mRNA splicing assays.
    Thompson BA; Martins A; Spurdle AB
    Clin Genet; 2015 Feb; 87(2):100-8. PubMed ID: 24989436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects.
    Tournier I; Vezain M; Martins A; Charbonnier F; Baert-Desurmont S; Olschwang S; Wang Q; Buisine MP; Soret J; Tazi J; Frébourg T; Tosi M
    Hum Mutat; 2008 Dec; 29(12):1412-24. PubMed ID: 18561205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of germline genetic mutations in patients with pancreatic cancer.
    Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
    Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four novel germline mutations in the MLH1 and PMS2 mismatch repair genes in patients with hereditary nonpolyposis colorectal cancer.
    Montazer Haghighi M; Radpour R; Aghajani K; Zali N; Molaei M; Zali MR
    Int J Colorectal Dis; 2009 Aug; 24(8):885-93. PubMed ID: 19479271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutation analysis of MLH1 and MSH2 in Malaysian Lynch syndrome patients.
    Zahary MN; Kaur G; Abu Hassan MR; Singh H; Naik VR; Ankathil R
    World J Gastroenterol; 2012 Feb; 18(8):814-20. PubMed ID: 22371642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing.
    Auclair J; Busine MP; Navarro C; Ruano E; Montmain G; Desseigne F; Saurin JC; Lasset C; Bonadona V; Giraud S; Puisieux A; Wang Q
    Hum Mutat; 2006 Feb; 27(2):145-54. PubMed ID: 16395668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel and rapid method of determining the effect of unclassified MLH1 genetic variants on differential allelic expression.
    Perera S; Li B; Tsitsikotas S; Ramyar L; Pollett A; Semotiuk K; Bapat B
    J Mol Diagn; 2010 Nov; 12(6):757-64. PubMed ID: 20864636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten novel MSH2 and MLH1 germline mutations in families with HNPCC.
    Krüger S; Bier A; Plaschke J; Höhl R; Aust DE; Kreuz FR; Pistorius SR; Saeger HD; Rothhammer V; Al-Taie O; Schackert HK
    Hum Mutat; 2004 Oct; 24(4):351-2. PubMed ID: 15365996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
    Buchanan DD; Tan YY; Walsh MD; Clendenning M; Metcalf AM; Ferguson K; Arnold ST; Thompson BA; Lose FA; Parsons MT; Walters RJ; Pearson SA; Cummings M; Oehler MK; Blomfield PB; Quinn MA; Kirk JA; Stewart CJ; Obermair A; Young JP; Webb PM; Spurdle AB
    J Clin Oncol; 2014 Jan; 32(2):90-100. PubMed ID: 24323032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression defect size among unclassified MLH1 variants determines pathogenicity in Lynch syndrome diagnosis.
    Hinrichsen I; Brieger A; Trojan J; Zeuzem S; Nilbert M; Plotz G
    Clin Cancer Res; 2013 May; 19(9):2432-41. PubMed ID: 23403630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of ambiguous mutations in DNA mismatch repair genes identified in a population-based study of colorectal cancer.
    Barnetson RA; Cartwright N; van Vliet A; Haq N; Drew K; Farrington S; Williams N; Warner J; Campbell H; Porteous ME; Dunlop MG
    Hum Mutat; 2008 Mar; 29(3):367-74. PubMed ID: 18033691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the translation initiation landscape of an S. cerevisiae gene using fluorescent proteins.
    Ben-Yehezkel T; Zur H; Marx T; Shapiro E; Tuller T
    Genomics; 2013 Oct; 102(4):419-29. PubMed ID: 23726901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.